The centre emphasizes the importance of collaboration with various clinical and research groups at Oslo University Hospital (OUS), highlighting the proximity to the institute as a significant advantage.
Clinical Trials: The centre is actively involved in numerous ongoing investigator-initiated studies.
Goals:
Develop new therapeutic strategies for both early and metastatic breast cancer.
Contribute to more individualized and improved breast cancer treatments.
Enhance precision in selecting patients who do not require systemic adjuvant therapy.
Increase participation in international multicenter studies.
Anne Alexandra Østgaard, study nurse; Helle Kristine Skjerven, surgeon, Head of the Section for Breast and Endocrine Surgery; Randi Ruud Mathiesen, oncologist, Head of the Centre for Breast Cancer, Head of the Section for Breast Oncology; Bjørn Naume, oncologist, Head of the Clinical Research Group for Breast Cancer; Therese Sørlie, researcher, Head the Department for Cancer Genetics; Vigdis Sandviken Opperud, consultant; Linda Romundstad, radiologist, Department head at the Breast Diagnostic Centre; Eva Mari A. Harboe, cancer nurse, course coordinator; Jon Lømo, pathologist with specialist responsibility for breast. (click for larger image). Photo: Per Marius Didriksen
Brandal SHB, Mo T, Fangberget A, Nilsen LB, Geier OM, Bjørndal H, Holmen MM, Engebråten O, Garred Ø, Hole KH, Seierstad T(2026) MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer Cancers (Basel), 18(3) DOI 10.3390/cancers18030393, PubMed 41681863
Hjorth S, Vandraas KF, Trewin-Nybråten CB, Botteri E, Ursin G, Andreassen BK, Støer NC(2026) Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently Breast Cancer Res Treat, 215(2), 54 DOI 10.1007/s10549-025-07888-z, PubMed 41498846
Husby M, Frydenberg H, Myklebust TÅ, Skei NV, Solligård E, Thune I, Gustad LT, Furberg AS(2026) Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway Cancer Epidemiol Biomarkers Prev, 35(2), 264-275 DOI 10.1158/1055-9965.EPI-25-1018, PubMed 41324403